Client Support
+19294669944
Respiratory Distress Syndrome

Respiratory Distress Syndrome

Respiratory Distress Syndrome

Respiratory Distress Syndrome is a serious condition in newborns characterized by difficulty breathing due to immature lungs. Surfactant replacement therapy is the gold standard treatment, which helps reduce inflammation and improve lung function.
Read our guide to:   Respiratory Distress Syndrome
Respiratory Distress Syndrome

How Respiratory Distress Syndrome Medications Work

Respiratory Distress Syndrome (RDS) is a life-threatening condition that affects newborns, particularly those born prematurely. The primary cause of RDS is the lack of surfactant in the lungs, which leads to difficulty breathing and oxygenation.

Treatment Goals

  • Stabilize respiratory function
  • Improve oxygen saturation
  • Reduce mortality and morbidity

Mechanism of Action: Surfactant Replacement Therapy (Gold Standard)

The gold standard treatment for RDS is surfactant replacement therapy. This involves administering a synthetic or natural surfactant to the newborn's lungs to reduce surface tension, allowing the alveoli to expand and contract more easily.

Alternative Therapies

  • Nitric oxide therapy: helps relax airway smooth muscles, improving oxygenation and reducing pulmonary hypertension
  • High-frequency ventilation: provides gentle, high-speed breaths to support lung expansion and gas exchange
  • Extracorporeal membrane oxygenation (ECMO): a life-support therapy that takes over respiratory and cardiac function when conventional treatments fail